What Schools Are Affiliated With Joseph P. Broderick

Joseph P. Broderick is affiliated with the following schools: Ohio State University, University of Minnesota, Medical University of South Carolina, Vanderbilt University, Stanford University, Georgetown University, University of Pittsburgh, Fudan University, Federal University of Rio Grande do Sul, University of Calgary, University of Cincinnati, Emory University, University of Sydney, Wake Forest University, University of Melbourne, University of Michigan, University of Eastern Finland, Cornell University, University of Glasgow, University of Virginia, University of California, San Francisco, Massachusetts General Hospital, Brown University, Yale University

Joseph P. Broderick | Academic Influence

Joseph P. Broderick's AcademicInfluence.com Rankings

Joseph P. Broderick

Philosophy

#3702

World Rank

#5931

Historical Rank

Logic

#1340

World Rank

#2065

Historical Rank

philosophy Degrees

Joseph P. Broderick

Biology

#4666

World Rank

#6936

Historical Rank

Neuroscience

#502

World Rank

#521

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Joseph P. Broderick's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Joseph P. Broderick Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Joseph P. Broderick's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1995) (8951)
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association (2010) (2887)
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials (2004) (2577)
An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2013) (2181)
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging (2018) (1931)
The ABCs of measuring intracerebral hemorrhage volumes. (1996) (1776)
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. (2013) (1764)
Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality (1993) (1548)
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults. 2007 Update. Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Gro (2007) (1311)
Early hemorrhage growth in patients with intracerebral hemorrhage. (1997) (1098)
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. (2008) (1096)
Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke: A Consensus Statement (2013) (1075)
Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group (2010) (1055)
Heart disease and stroke. (1993) (896)
Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. (1999) (887)
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage (2006) (790)
The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. (1998) (758)
Spontaneous intracerebral hemorrhage. (2001) (718)
Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. (1999) (641)
Cincinnati Prehospital Stroke Scale: reproducibility and validity. (1999) (591)
Initial and Recurrent Bleeding Are the Major Causes of Death Following Subarachnoid Hemorrhage (1994) (572)
Guidelines for the Management of Patients With Unruptured Intracranial Aneurysms: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association (2015) (572)
Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes (1992) (569)
Effects of tissue plasminogen activator for acute ischemic stroke at one year (1999) (555)
Phenylpropanolamine and the risk of hemorrhagic stroke. (2000) (552)
Public perception of stroke warning signs and knowledge of potential risk factors. (1998) (548)
Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. (1993) (543)
The Heidelberg Bleeding Classification: Classification of Bleeding Events After Ischemic Stroke and Reperfusion Therapy. (2015) (526)
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial (2002) (496)
Good clinical outcome after ischemic stroke with successful revascularization is time-dependent (2009) (493)
The increasing incidence of anticoagulant-associated intracerebral hemorrhage (2007) (448)
The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. (1992) (443)
Age at stroke (2012) (436)
Acute Stroke Care in the US: Results from 4 Pilot Prototypes of the Paul Coverdell National Acute Stroke Registry (2005) (434)
Incidence and Short-Term Prognosis of Transient Ischemic Attack in a Population-Based Study (2005) (433)
Stroke in a Biracial Population: The Excess Burden of Stroke Among Blacks (2004) (413)
Genetic and Environmental Risk Factors for Intracerebral Hemorrhage: Preliminary Results of a Population-Based Study (2002) (408)
Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening (2014) (405)
Early stroke treatment associated with better outcome The NINDS rt-PA Stroke Study (2000) (398)
Long-term mortality after intracerebral hemorrhage (2006) (382)
Trends in community knowledge of the warning signs and risk factors for stroke. (2003) (376)
Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. (2001) (375)
Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial (2014) (369)
Revascularization Results in the Interventional Management of Stroke II Trial (2008) (349)
Patients' awareness of stroke signs, symptoms, and risk factors. (1997) (338)
Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. (1998) (332)
Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. (2005) (328)
Risk factors : Prevention and Rehabilitation of Stroke (1997) (327)
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke. (2016) (324)
Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. (1996) (322)
Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials. (2017) (321)
Stroke in Children Within a Major Metropolitan Area: The Surprising Importance of Intracerebral Hemorrhage (1993) (321)
Relative Edema Volume Is a Predictor of Outcome in Patients With Hyperacute Spontaneous Intracerebral Hemorrhage (2002) (317)
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke (1998) (314)
Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. (2003) (310)
Stroke Incidence Is Decreasing in Whites But Not in Blacks: A Population-Based Estimate of Temporal Trends in Stroke Incidence From the Greater Cincinnati/Northern Kentucky Stroke Study (2010) (309)
Gene Expression in Blood Changes Rapidly in Neutrophils and Monocytes after Ischemic Stroke in Humans: A Microarray Study (2006) (307)
Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. (1999) (306)
Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Population-Based Study (2004) (304)
Determinants of Intracerebral Hemorrhage Growth: An Exploratory Analysis (2007) (303)
Acute Stroke Imaging Research Roadmap II (2008) (299)
Diagnosis and management of neurological sarcoidosis. (1997) (294)
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. (1997) (294)
National US Estimates of Recombinant Tissue Plasminogen Activator Use: ICD-9 Codes Substantially Underestimate (2008) (282)
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. (1999) (280)
A Modified National Institutes of Health Stroke Scale for Use in Stroke Clinical Trials: Preliminary Reliability and Validity (2001) (277)
Methodology of the Interventional Management of Stroke III Trial (2008) (274)
An Updated Definition of Stroke for the 21 st Century (2013) (270)
Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. (1995) (256)
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage (2010) (256)
Carotid Artery Stenosis as a Cause of Stroke (2012) (253)
Incidence rates of stroke in the eighties: the end of the decline in stroke? (1989) (252)
Collaterals at Angiography and Outcomes in the Interventional Management of Stroke (IMS) III Trial (2014) (252)
Acute stroke: delays to presentation and emergency department evaluation. (1999) (251)
Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. (1996) (251)
Racial Variations in Location and Risk of Intracerebral Hemorrhage (2005) (250)
Association of Serial Biochemical Markers With Acute Ischemic Stroke: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study (2006) (249)
The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods (2018) (249)
Ultra-early evaluation of intracerebral hemorrhage. (1990) (248)
Dynamics of Intraventricular Hemorrhage in Patients with Spontaneous Intracerebral Hemorrhage: Risk Factors, Clinical Impact, and Effect of Hemostatic Therapy with Recombinant Activated Factor VII (2006) (247)
Ischemic Stroke Subtypes: A Population-Based Study of Incidence Rates Among Blacks and Whites (2004) (245)
Subarachnoid Hemorrhage: A Preventable Disease With a Heritable Component (2002) (232)
Safety and Feasibility of Recombinant Factor VIIa for Acute Intracerebral Hemorrhage (2005) (228)
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. (1999) (225)
Relationship of Cardiac Disease to Stroke Occurrence, Recurrence, and Mortality (1992) (223)
The Unchanging Incidence and Case-Fatality of Stroke in the 1990s: A Population-Based Study (2006) (222)
Hypertension and its treatment in the NINDS rt-PA Stroke Trial. (1998) (221)
Lessons Learned from Whole Exome Sequencing in Multiplex Families Affected by a Complex Genetic Disorder, Intracranial Aneurysm (2015) (221)
Natural History of Perihematomal Edema in Patients With Hyperacute Spontaneous Intracerebral Hemorrhage (2002) (220)
Revascularization End Points in Stroke Interventional Trials: Recanalization Versus Reperfusion in IMS-I (2005) (219)
Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage. (2014) (217)
Factors Related to Intracranial Hematoma Formation in Patients Receiving Tissue‐Type Plasminogen Activator forAcute Ischemic Stroke (1994) (216)
The American Heart Association Stroke Outcome Classification. (1998) (211)
Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. (1999) (210)
Design and Validation of a Prehospital Scale to Predict Stroke Severity: Cincinnati Prehospital Stroke Severity Scale (2015) (209)
Density and Shape as CT Predictors of Intracerebral Hemorrhage Growth (2009) (208)
Incidence of seizures in the acute phase of stroke: A population‐based study (2008) (206)
Intracranial Hemorrhage Associated With Revascularization Therapies (2007) (206)
A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3) (2017) (203)
Time of hospital presentation in patients with acute stroke. (1993) (195)
Individual Patient Data Subgroup Meta-Analysis of Surgery for Spontaneous Supratentorial Intracerebral Hemorrhage (2012) (195)
Frequency and accuracy of prehospital diagnosis of acute stroke. (1995) (193)
Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data (2018) (183)
An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. ACAS Investigators. Asymptomatic Carotid Atherosclerosis Study. (1996) (181)
Epidemiological Characteristics of Lacunar Infarcts in a Population (1991) (180)
Impact of Onset-to-Reperfusion Time on Stroke Mortality: A Collaborative Pooled Analysis (2013) (179)
Major Risk Factors for Aneurysmal Subarachnoid Hemorrhage in the Young Are Modifiable (2003) (179)
Early stroke recognition: developing an out-of-hospital NIH Stroke Scale. (1997) (178)
tPA and proteolysis in the neurovascular unit. (2004) (177)
Designing a Message for Public Education Regarding Stroke: Does FAST Capture Enough Stroke? (2007) (174)
Advances in the management of intracerebral hemorrhage (2010) (174)
Combined Intravenous and Intra-Arterial Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke (2000) (173)
Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group. (1993) (172)
APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study (2011) (169)
Ultra-early clot aspiration after lysis with tissue plasminogen activator in a porcine model of intracerebral hemorrhage: edema reduction and blood-brain barrier protection. (1999) (166)
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. (2012) (165)
Effect of Untreated Hypertension on Hemorrhagic Stroke (2004) (163)
Greater Rupture Risk for Familial as Compared to Sporadic Unruptured Intracranial Aneurysms (2009) (159)
Major Risk Factors for Intracerebral Hemorrhage in the Young Are Modifiable (2005) (158)
Can a Subset of Intracerebral Hemorrhage Patients Benefit From Hemostatic Therapy With Recombinant Activated Factor VII? (2009) (156)
Relationship of National Institutes of Health Stroke Scale to 30-Day Mortality in Medicare Beneficiaries With Acute Ischemic Stroke (2012) (155)
The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke: The CLEAR Stroke Trial (2008) (153)
Efficacy of Home-Based Telerehabilitation vs In-Clinic Therapy for Adults After Stroke: A Randomized Clinical Trial. (2019) (153)
Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. (2014) (150)
Temporal Trends in Public Awareness of Stroke: Warning Signs, Risk Factors, and Treatment (2009) (150)
Clinical Prediction of Functional Outcome After Ischemic Stroke: The Surprising Importance of Periventricular White Matter Disease and Race (2009) (147)
Baseline Silent Cerebral Infarction in the Asymptomatic Carotid Atherosclerosis Study (1994) (144)
Lack of Evidence for an Association Between Hemodynamic Variables and Hematoma Growth in Spontaneous Intracerebral Hemorrhage (2006) (137)
Diabetes Mellitus: A Risk Factor for Ischemic Stroke in a Large Biracial Population (2013) (137)
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial (2018) (132)
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial (2018) (132)
Finding the Most Powerful Measures of the Effectiveness of Tissue Plasminogen Activator in the NINDS tPA Stroke Trial (2000) (131)
Lobar Hemorrhage in the Elderly: The Undiminishing Importance of Hypertension (1993) (131)
Perimesencephalic subarachnoid hemorrhage: incidence, risk factors, and outcome. (2005) (126)
Thromboembolic Events With Recombinant Activated Factor VII in Spontaneous Intracerebral Hemorrhage: Results From the Factor Seven for Acute Hemorrhagic Stroke (FAST) Trial (2010) (123)
Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale (2015) (120)
Gene Expression Profiling of Blood for the Prediction of Ischemic Stroke (2010) (119)
Standardizing the Structure of Stroke Clinical and Epidemiologic Research Data: The National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) Project (2012) (119)
Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies. (2000) (119)
Signatures of cardioembolic and large‐vessel ischemic stroke (2010) (118)
Alberta Stroke Program Early Computed Tomography Score to Select Patients for Endovascular Treatment: Interventional Management of Stroke (IMS)-III Trial (2014) (116)
Recombinant activated factor VII for acute intracerebral hemorrhage. (2005) (115)
Thrombolytic therapy of acute ischemic stroke during pregnancy (2006) (114)
Urgent Therapy for Acute Stroke: Effects of a Stroke Trial on Untreated Patients (1994) (114)
NIHSS Training and Certification Using a New Digital Video Disk Is Reliable (2005) (114)
Migraine-related strokes. Clinical profile and prognosis in 20 patients. (1987) (113)
Is periprocedural sedation during acute stroke therapy associated with poorer functional outcomes? (2009) (113)
Risk factors for intracerebral hemorrhage differ according to hemorrhage location (2012) (113)
Blood pressure during the first minutes of focal cerebral ischemia. (1993) (111)
Genome-Wide Association Study of Intracranial Aneurysms Confirms Role of Anril and SOX17 in Disease Risk (2012) (109)
Management of intracerebral hemorrhage in a large metropolitan population. (1994) (107)
Screening for brain aneurysm in the Familial Intracranial Aneurysm study: frequency and predictors of lesion detection. (2008) (106)
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial (2018) (102)
Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial (2015) (101)
Clinical Selection Strategies to Identify Ischemic Stroke Patients With Large Anterior Vessel Occlusion: Results From SITS-ISTR (Safe Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Registry) (2017) (100)
Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence (2011) (99)
Trends in Substance Abuse Preceding Stroke Among Young Adults: A Population-Based Study (2012) (98)
Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage. (2000) (97)
Evaluation of Interval Times From Onset to Reperfusion in Patients Undergoing Endovascular Therapy in the Interventional Management of Stroke III Trial (2014) (96)
Using the baseline CT scan to select acute stroke patients for IV-IA therapy. (2006) (94)
Impact of General Anesthesia on Safety and Outcomes in the Endovascular Arm of Interventional Management of Stroke (IMS) III Trial (2015) (93)
Translational Stroke Research: Vision and Opportunities (2017) (93)
Derivation of Transcranial Doppler Criteria for Rescue Intra-arterial Thrombolysis: Multicenter Experience From the Interventional Management of Stroke Study (2005) (93)
Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors (2020) (92)
Recombinant tissue plasminogen activator for minor strokes: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience (2005) (91)
Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke–Enhanced Regimen Stroke Trial (2013) (91)
Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke–Enhanced Regimen Stroke Trial (2013) (91)
Hyperglycemia and hemorrhagic transformation of cerebral infarcts. (1995) (90)
Thrombectomy for Stroke in the Public Health Care System of Brazil. (2020) (90)
Current Status of Acute Stroke Management in Korea: A Report on a Multicenter, Comprehensive Acute Stroke Registry (2014) (88)
Spontaneous intracerebral hemorrhage: epidemiology and clinical presentation. (2002) (87)
Community Socioeconomic Status and Prehospital Times in Acute Stroke and Transient Ischemic Attack: Do Poorer Patients Have Longer Delays From 911 Call to the Emergency Department? (2006) (87)
Strokes With Minor Symptoms: An Exploratory Analysis of the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trials (2010) (86)
Recombinant activated factor VII for acute intracerebral hemorrhage US phase IIA trial (2006) (85)
Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials (2017) (85)
Selective Serotonin Reuptake Inhibitors and Risk of Hemorrhagic Stroke (2007) (85)
Location and outcome of anticoagulant-associated intracerebral hemorrhage (2006) (84)
Thrombus localization with emergency cerebral CT. (1992) (82)
Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet. (2017) (81)
Gene Expression in Peripheral Blood Differs after Cardioembolic Compared with Large-Vessel Atherosclerotic Stroke: Biomarkers for the Etiology of Ischemic Stroke (2008) (81)
Smoking and family history and risk of aneurysmal subarachnoid hemorrhage (2009) (80)
William M. Feinberg Lecture: stroke therapy in the year 2025: burden, breakthroughs, and barriers to progress. (2003) (78)
Hypercholesterolemia, HMG-CoA Reductase Inhibitors, and Risk of Intracerebral Hemorrhage: A Case–Control Study (2004) (78)
Association of Apolipoprotein E4 and Haplotypes of the Apolipoprotein E Gene With Lobar Intracerebral Hemorrhage (2005) (77)
Transcranial Laser Therapy in Acute Stroke Treatment: Results of Neurothera Effectiveness and Safety Trial 3, a Phase III Clinical End Point Device Trial (2014) (76)
Carotid stenting and angioplasty: a statement for healthcare professionals from the Councils on Cardiovascular Radiology, Stroke, Cardio-Thoracic and Vascular Surgery, Epidemiology and Prevention, and Clinical Cardiology, American Heart Association. (1998) (74)
Association of Phosphodiesterase 4D with ischemic stroke: a population-based case-control study. (2006) (74)
Rationale, Design, and Progress of the ENhanced Control of Hypertension ANd Thrombolysis Stroke Study (ENCHANTED) Trial: An International Multicenter 2 × 2 Quasi-Factorial Randomized Controlled Trial of Low- vs. Standard-Dose rt-PA and Early Intensive vs. Guideline-Recommended Blood Pressure Lowerin (2015) (74)
The American Heart Association Stroke Outcome Classification: executive summary. (1998) (73)
Emergency physicians. Accuracy in the diagnosis of stroke. (1995) (72)
Review, Historical Context, and Clarifications of the NINDS rt-PA Stroke Trials Exclusion Criteria: Part 1 Rapidly Improving Stroke Symptoms (2013) (72)
Three-dimensional anatomical model-based segmentation of MR brain images through principal axes registration (1995) (70)
Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion (2012) (69)
Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome (2019) (68)
The Familial Intracranial Aneurysm (FIA) study protocol (2005) (67)
Gene Expression in Peripheral Immune Cells following Cardioembolic Stroke Is Sexually Dimorphic (2014) (66)
Microcatheter Contrast Injections During Intra-Arterial Thrombolysis May Increase Intracranial Hemorrhage Risk (2008) (66)
Prospective Prehospital Evaluation of the Cincinnati Stroke Triage Assessment Tool (2017) (64)
Temporal Trends in the Incidence and Case Fatality of Stroke in Children and Adolescents (2006) (63)
Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia. (2017) (63)
Endovascular Therapy for Acute Ischemic Stroke (2009) (62)
Emergency medical services use by stroke patients: a population-based study. (2009) (61)
Sex-specific stroke incidence over time in the Greater Cincinnati/Northern Kentucky Stroke Study (2017) (61)
Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials. (2019) (60)
Stroke trends in Rochester, Minnesota, during 1945 to 1984. (1993) (60)
Comprehensive Stroke Centers and the ‘Weekend Effect’: The SPOTRIAS Experience (2012) (59)
Seizures are Common in the Acute Setting of Childhood Stroke: A Population-Based Study (2009) (59)
Effects of Gender on Gene Expression in the Blood of Ischemic Stroke Patients (2012) (58)
Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial (2021) (57)
Association of ALOX5AP with ischemic stroke: a population-based case-control study (2007) (56)
Impact of socioeconomic status on stroke incidence: A population‐based study (2006) (55)
Pilot Randomized Trial of Tissue Plasminogen Activator in Acute Ischemic Stroke (1993) (54)
Patient-Level and Hospital-Level Determinants of the Quality of Acute Stroke Care: A Multilevel Modeling Approach (2010) (54)
Carotid stenting and angioplasty: a statement for healthcare professionals from the Councils on Cardiovascular Radiology, Stroke, Cardio-Thoracic and Vascular Surgery, Epidemiology, and Prevention, and Clinical Cardiology, American Heart Association. (1998) (54)
Stroke Outcomes Measures Must Be Appropriately Risk Adjusted to Ensure Quality Care of Patients: A Presidential Advisory From the American Heart Association/American Stroke Association (2014) (54)
Which stroke symptoms prompt a 911 call? A population-based study. (2010) (54)
Stable incidence but declining case-fatality rates of subarachnoid hemorrhage in a population (2016) (54)
Genome-Wide Association Study of Intracranial Aneurysm Identifies a New Association on Chromosome 7 (2014) (53)
Genome Screen to Detect Linkage to Intracranial Aneurysm Susceptibility Genes: The Familial Intracranial Aneurysm (FIA) Study (2008) (53)
Peripheral monocyte count is associated with case fatality after intracerebral hemorrhage. (2014) (53)
Risk of Thromboembolic Events in Controlled Trials of rFVIIa in Spontaneous Intracerebral Hemorrhage (2008) (52)
Advances and challenges in treatment and prevention of ischemic stroke (2013) (51)
The Paul Coverdell National Acute Stroke Registry: initial results from four prototypes. (2006) (51)
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke (2001) (50)
Unruptured intracranial aneurysms in the Familial Intracranial Aneurysm and International Study of Unruptured Intracranial Aneurysms cohorts: differences in multiplicity and location. (2012) (50)
The Relationship Between Smoking and Replicated Sequence Variants on Chromosomes 8 and 9 With Familial Intracranial Aneurysm (2010) (49)
The X-Chromosome Has a Different Pattern of Gene Expression in Women Compared With Men With Ischemic Stroke (2012) (48)
RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke (2013) (48)
Potentially Missed Diagnosis of Ischemic Stroke in the Emergency Department in the Greater Cincinnati/Northern Kentucky Stroke Study. (2016) (47)
Burden of Risk Alleles for Hypertension Increases Risk of Intracerebral Hemorrhage (2012) (47)
Temporal Trends in Stroke Incidence Over Time by Sex and Age in the GCNKSS (2020) (46)
Treatment of acute ischemic stroke: Part I: recanalization strategies. (2002) (46)
Management of Intracerebral Hemorrhage in a Large Metropolitan Population (1994) (46)
Basilar Occlusion Syndromes (2015) (45)
Consistency of Doppler parameters in predicting arteriographically confirmed carotid stenosis. Asymptomatic Carotid Atherosclerosis Study Investigators. (1997) (44)
How Often Are Patients With Ischemic Stroke Eligible for Decompressive Hemicraniectomy? (2012) (44)
Intracerebral hemorrhage volume measurement. (1994) (43)
3-D image analysis of intra-cerebral brain hemorrhage from digitized CT films. (1995) (43)
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. ONTARGET Renal Outcomes TRANSCEND (2008) (43)
Apolipoprotein E, Statins, and Risk of Intracerebral Hemorrhage (2013) (42)
Thrombolytic Therapy for Stroke (2001) (42)
Reperfusion activates metalloproteinases that contribute to neurovascular injury (2008) (42)
Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study) (2017) (42)
Erratum: Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke (Stroke (August 2003) 34:8 (1156-1162)) (2003) (41)
Endovascular Therapy for Patients With Acute Ischemic Stroke During the COVID-19 Pandemic: A Proposed Algorithm (2020) (41)
Quantitative intracerebral brain hemorrhage analysis (1999) (41)
Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats (2010) (40)
Common mitochondrial sequence variants in ischemic stroke (2011) (39)
Validity of a retrospective National Institutes of Health Stroke Scale scoring methodology in patients with severe stroke. (2005) (39)
The STICH trial: what does it tell us and where do we go from here? (2005) (39)
Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial (2015) (39)
Treatment of acute ischemic stroke: Part II: neuroprotection and medical management. (2002) (39)
Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data. (2015) (39)
Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research (2005) (39)
National Institutes of Health Stroke Scale (2019) (39)
Effect of endovascular reperfusion in relation to site of arterial occlusion (2016) (38)
Medication Errors in Acute Cardiac Care: An American Heart Association Scientific Statement From the Council on Clinical Cardiology Subcommittee on Acute Cardiac Care, Council on Cardiopulmonary and Critical Care, Council on Cardiovascular Nursing, and Council on Stroke (2002) (38)
Profiles of the National Institutes of Health Stroke Scale Items as a Predictor of Patient Outcome (2013) (37)
Greater Cincinnati/Northern Kentucky Stroke Study: Volume of First-Ever Ischemic Stroke Among Blacks in a Population-Based Study (2001) (37)
Mechanical reperfusion is associated with post-ischemic hemorrhage in rat brain (2009) (37)
Shared Genetic Risk Factors of Intracranial, Abdominal, and Thoracic Aneurysms (2016) (37)
Quality assessment of buccal versus blood genomic DNA using the Affymetrix 500 K GeneChip (2007) (37)
Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke-Full Dose Regimen (CLEAR-FDR Stroke Trial) (2015) (36)
Anterior Cerebral Artery Emboli in Combined Intravenous and Intra-arterial rtPA Treatment of Acute Ischemic Stroke in the IMS I and II Trials (2007) (36)
Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3: Post Hoc Analysis (2015) (36)
Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions (2014) (36)
Comparison of two depression measures for predicting stroke outcomes. (2012) (36)
Basic and Translational Research in Intracerebral Hemorrhage: Limitations, Priorities, and Recommendations (2018) (34)
Focal encephalitis in a young woman 6 years after the onset of Lyme disease: tertiary Lyme disease? (1987) (34)
Common Variants Within Oxidative Phosphorylation Genes Influence Risk of Ischemic Stroke and Intracerebral Hemorrhage (2013) (33)
ASPECTS score to select patients for endovascular treatment: the IMS-III trial (2014) (33)
Unmet Needs and Challenges in Clinical Research of Intracerebral Hemorrhage. (2018) (33)
Anti-N-methyl-D-aspartate receptor encephalitis: characteristic behavioral and movement disorder. (2010) (32)
Interventional Management of Stroke (IMS III) Trial (2011) (32)
Paranoid psychosis due to neurosarcoidosis. (1994) (32)
State of acute endovascular therapy: report from the 12th thrombolysis, thrombectomy, and acute stroke therapy conference. (2015) (32)
Thrombolytic therapy for stroke (1994) (32)
Pediatric Stroke Rates Over 17 Years: Report From a Population-Based Study (2018) (32)
Y chromosome gene expression in the blood of male patients with ischemic stroke compared with male controls. (2012) (31)
What the SWIFT and TREVO II Trials Tell Us About the Role of Endovascular Therapy for Acute Stroke (2013) (31)
Microcatheter contrast injections during intra-arterial thrombolysis increase intracranial hemorrhage risk (2010) (31)
Genome screen in familial intracranial aneurysm (2009) (30)
Time to Angiographic Reperfusion in Acute Ischemic Stroke: Decision Analysis (2014) (30)
Carotid stenting and angioplasty: a statement for healthcare professionals from the Councils on Cardiovascular Radiology, Stroke, Cardiovascular Surgery, Epidemiology and Prevention, and Clinical Cardiology, American Heart Association. (1998) (30)
Soluble ST2 predicts outcome and hemorrhagic transformation after acute stroke (2017) (30)
Emergency Department Arrival Times after Acute Ischemic Stroke During the 1990s (2007) (29)
Transitions of Care for Stroke Patients: Opportunities to Improve Outcomes. (2015) (29)
Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome. (2005) (29)
Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial (2017) (28)
Prehospital Triage of Acute Ischemic Stroke Patients to an Intravenous tPA-Ready versus Endovascular-Ready Hospital: A Decision Analysis (2018) (28)
Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes (2017) (28)
Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onset. (2001) (27)
Intracerebral Hemorrhage: The epidemiology of intracerebral hemorrhage (2009) (27)
Intracerebral hemorrhage. (2000) (27)
The challenges of intracranial revascularization for stroke prevention. (2011) (27)
Intraarterial recombinant tissue plasminogen activator for ischemic stroke: an accelerated dosing regimen. (2001) (27)
Challenges of Acute Endovascular Stroke Trials (2014) (27)
Stroke Treatment Academic Industry Roundtable: Research Priorities in the Assessment of Neurothrombectomy Devices (2013) (27)
National Institutes of Health Stroke Scale Item Profiles as Predictor of Patient Outcome: External Validation on Independent Trial Data (2015) (27)
The challenge of designing a treatment trial for warfarin-associated intracerebral hemorrhage. (2009) (27)
Stroke: Pathophysiology, Diagnosis, and Management (2015) (26)
Estimated Impact of Emergency Medical Service Triage of Stroke Patients on Comprehensive Stroke Centers: An Urban Population-Based Study (2017) (26)
Recanalization therapies for acute ischemic stroke. (1998) (26)
Practical considerations in the early treatment of ischemic stroke. (1998) (25)
The National Institutes of Health StrokeNet: A User's Guide. (2016) (24)
Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studies. (2014) (24)
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke (2005) (24)
Cost of Alteplase Has More Than Doubled Over the Past Decade (2017) (23)
Multicenter Accuracy and Interobserver Agreement of Spot Sign Identification in Acute Intracerebral Hemorrhage (2014) (23)
Imaging in StrokeNet: Realizing the Potential of Big Data (2015) (23)
Endovascular Treatment in the DEFUSE 3 Study (2018) (23)
Variability in the use of intravenous thrombolysis for mild stroke: experience across the SPOTRIAS network. (2013) (23)
Design of the Economic Evaluation for the Interventional Management of Stroke (III) Trial (2008) (23)
Matrix metalloproteinase-2 deletions protect against hemorrhagic transformation after 1h of cerebral ischemia and 23h of reperfusion (2013) (22)
Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial (2015) (22)
Potential Applicability of Recombinant Factor VIIa for Intracerebral Hemorrhage (2005) (21)
Smoking cessation after stroke: education and its effect on behavior. (2005) (21)
Genetics of intracranial aneurysm. (2002) (21)
Global Differences in Patient Characteristics, Case Management and Outcomes in Intracerebral Hemorrhage: The Factor Seven for Acute Hemorrhagic Stroke (FAST) Trial (2009) (21)
Genome Screen to Detect Linkage to Common Susceptibility Genes for Intracranial and Aortic Aneurysms (2009) (21)
Subarachnoid hemorrhage: tests of association with apolipoprotein E and elastin genes (2007) (21)
Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis. (2015) (21)
Design and rationale for examining neuroimaging genetics in ischemic stroke (2017) (21)
Shared Genetic Risk Factors of Intracranial, Abdominal, and Thoracic Aneurysms (2016) (20)
SURGICAL MANAGEMENT AND CASE‐FATALITY RATES OF INTRACEREBRAL HEMORRHAGE IN 1988 AND 2005 (2008) (19)
Nonconvulsive status epilepticus in a patient with leptomeningeal cancer. (1987) (19)
Capillary Index Score in the Interventional Management of Stroke Trials I and II (2014) (19)
Effect of COVID-19 on Emergent Stroke Care (2020) (18)
Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography. (2008) (18)
Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial (2019) (18)
Relative Influence of Capillary Index Score, Revascularization, and Time on Stroke Outcomes From the Interventional Management of Stroke III Trial (2015) (18)
Increasing Use of CT Angiography in Interventional Study Sites: The IMS III Experience (2010) (17)
Sleep for Stroke Management and Recovery Trial (Sleep SMART): Rationale and methods (2020) (17)
A Description of Canadian and United States Physician Reimbursement for Thrombolytic Therapy Administration in Acute Ischemic Stroke (2005) (17)
Thrombolysis in patients with transient neurologic deficits (2001) (17)
Drivers of Costs Associated With Reperfusion Therapy in Acute Stroke: The Interventional Management of Stroke III Trial (2014) (17)
Tribulations of stroke trials (2013) (17)
STAIR X: Emerging Considerations in Developing and Evaluating New Stroke Therapies (2018) (17)
Volumetric Measurement of Multifocal Brain Lesions: Implications for Treatment Trials of Vascular Dementia and Multiple Sclerosis (1996) (17)
Antithrombin therapy for intracerebral hemorrhage [4] (multiple letters) (2000) (16)
Is periprocedural sedation during acute stroke therapy associated with poorer functional outcomes? (2018) (16)
How Much Would Performing Diffusion-Weighted Imaging for All Transient Ischemic Attacks Increase MRI Utilization? (2010) (16)
Should intravenous thrombolysis be considered the first option in pregnant women? (2013) (16)
Acute stroke therapy at the crossroads. (2011) (16)
Is ED disposition associated with intracerebral hemorrhage mortality? (2011) (15)
Blood Pressure Target in Acute Stroke to Reduce HemorrhaGe After Endovascular Therapy: The Randomized BP TARGET Study Protocol (2020) (15)
High Blood Pressure Adults : 2007 Update : A Guideline From the American Heart Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in (2007) (15)
Familial Intracranial Aneurysms: Is Anatomic Vulnerability Heritable? (2013) (15)
A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: statistical analysis plan for a sequential meta-analysis performed within the VISTA-Endovascular (2015) (15)
Collagen COL22A1 maintains vascular stability and mutations in COL22A1 are potentially associated with intracranial aneurysms (2018) (15)
National Institutes of Health Stroke Scale Item Profiles as Predictor of Patient Outcome: External Validation on Safe Implementation of Thrombolysis in Stroke–Monitoring Study Data (2015) (14)
Observed Cost and Variations in Short Term Cost‐Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III (2017) (14)
Translational Stroke Research (2012) (14)
Carotid endarterectomy (2000) (14)
Depression is associated with impairment of ADL, not motor function in Parkinson disease. Authors' reply (2006) (14)
The effect of race and gender on patterns of rt-PA use within a population. (2003) (14)
Affected Twins in the Familial Intracranial Aneurysm Study (2015) (14)
Coiling, clipping, or medical management of unruptured intracranial aneurysms: Time to randomize? (2000) (14)
Biomarkers of Acute Stroke Etiology (BASE) Study Methodology (2017) (14)
Genetic epidemiology of intracerebral hemorrhage. (2005) (14)
Early Versus Late Assessment of Stroke Outcome. (2016) (13)
AHA/ASA Guideline Guidelines for the Management of Spontaneous Intracerebral Hemorrhage (2010) (13)
Emergency Department Adherence to American Heart Association Guidelines for Blood Pressure Management in Acute Ischemic Stroke (2012) (13)
THE ROLE OF RACE IN TIME TO TREATMENT AFTER SUBARACHNOID HEMORRHAGE (2007) (13)
Evolution of Practice During the Interventional Management of Stroke III Trial and Implications for Ongoing Trials (2014) (13)
The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methods (2020) (13)
The Story of Intracerebral Hemorrhage: From Recalcitrant to Treatable Disease. (2021) (13)
Very early edema growth not significantly associated with neurologic deterioration in patients with intracerebral hemorrhage (1995) (12)
To Treat or Not to Treat?: Exploring Factors Influencing Intravenous Thrombolysis Treatment Decisions for Minor Stroke (2018) (12)
Use of Intravenous Tissue Plasminogen Activator in a 16-Year-Old Patient with Basilar Occlusion (2008) (12)
Image analysis and 3-D visualization of intracerebral brain hemorrhage (1993) (12)
Brain distribution and elimination of recombinant human TIMP-1 after cerebral ischemia and reperfusion in rats (2011) (12)
Isoforms of apolipoprotein E can modulate tPA-induced clot lysis in vitro. (2002) (11)
Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial (2021) (11)
Endovascular treatment for acute ischemic stroke. (2013) (11)
Stroke Council, American Heart Association Statement for Healthcare Professionals From a Special Writing Group of the Guidelines for the Management of Spontaneous Intracerebral Hemorrhage : A (2006) (11)
Evidence against rapid reversal of antiplatelet medications in acute intracerebral hemorrhage (2009) (11)
Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and design (2018) (11)
Recanalization and Angiographic Reperfusion Are Both Associated with a Favorable Clinical Outcome in the IMS III Trial (2016) (10)
Withdrawal of Antithrombotic Agents and the Risk of Stroke. (2016) (10)
The use of standardized patients for mock oral board exams in neurology: a pilot study (2006) (10)
Temporal Changes in Brain Volume and Cognition in a Randomized Treatment Trial of Vascular Dementia (2001) (10)
Regulation and Governance of Multinational Drug Trials in Stroke: Barriers and Possibilities (2015) (10)
Reliability of the Barthel Index Outcome Measure Selected for the NINDS t-PA Stroke Trial (1995) (10)
Intense Arm Rehabilitation Therapy Improves the Modified Rankin Scale Score (2021) (10)
Parenchymal hematoma and total lesion volume in combined IV/IA revascularization stroke therapy (2011) (10)
Effect Size Estimates for the ESCAPE Trial: Proportional Odds Regression Versus Other Statistical Methods (2015) (10)
Design and rationale for examining neuroimaging genetics in ischemic stroke The MRI-GENIE study (10)
Temporal Trends of Sex Differences in Transient Ischemic Attack Incidence Within a Population. (2018) (10)
Association of Phosphodiesterase 4 D With Ischemic Stroke (2006) (10)
Facial paralysis and occult parotid cancer. A characteristic syndrome. (1988) (10)
Case of Small Vessel Disease Associated with COL4A1 Mutations following Trauma (2015) (9)
Thrombolytic therapy for cerebral infarction. (1996) (9)
Early Surgical Treatment for Supratentorial Intracerebral Hemorrhage (1999) (9)
Potential Impact of C-STAT for Prehospital Stroke Triage up to 24 Hours on a Regional Stroke System (2020) (9)
In Vitro Therapy with Dobutamine, Isoprenaline and Sodium Nitroprusside Protects Vascular Smooth Muscle Metabolism from Subarachnoid Haemorrhage Induced Cerebral Vasospasm (2001) (9)
Impact of Recombinant Activated Factor VII on Health-Related Quality of Life after Intracerebral Hemorrhage (2007) (9)
National Institutes of Health StrokeNet During the Time of COVID-19 and Beyond (2020) (9)
Challenges of Decision Making Regarding Futility in a Randomized Trial: The Interventional Management of Stroke III Experience (2014) (9)
Comparative effects of intensive-blood pressure versus standard-blood pressure-lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial (2020) (9)
Subgroup analysis in the fast trial: A subset of intracerebral hemorrhage patients that benefit from recombinant activated factor VII? (2008) (9)
Clipping or coiling: the first step for ruptured aneurysms (2009) (9)
Incidence Rates of Stroke for Blacks and Whites: Preliminary Results from the Greater Cincinnati/Northern Kentucky Stroke Study (2001) (8)
Acute Ischemic Stroke with Very Early Clinical Improvement: A National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trials Exploratory Analysis. (2016) (8)
Strategies for Early Treatment of Acute Cerebral Infarction (1991) (8)
Risk of thrombolysis-associated intracerebral hemorrhage: the need to compare apples with apples. (2005) (8)
A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke. (2014) (7)
Novel Insights Into the Genetics of Intracerebral Hemorrhage (2013) (7)
Heritability of circle of Willis variations in families with intracranial aneurysms (2018) (7)
Eligibility for the Surgical Trial in Intracerebral Hemorrhage II Study in a Population-based Cohort (2008) (7)
Towards personalised intra-arterial treatment of patients with acute ischaemic stroke: a study protocol for development and validation of a clinical decision aid (2017) (7)
Randomization of endovascular treatment with stent-retriever and/or thromboaspiration versus best medical therapy in acute ischemic stroke due to large vessel occlusion trial: Rationale and design (2019) (7)
PFO Closure for Cryptogenic Stroke. (2018) (7)
Reimbursement for thrombectomy devices in patients who are ineligible for intravenous tissue-type plasminogen activator. (2013) (7)
External carotid artery embolus with internal carotid artery occlusion with acute ischemic stroke: predictor of cardioembolic etiology (2011) (7)
Response to ethical challenges in stroke research (1998) (7)
Advances in the treatment of hemorrhagic stroke: a possible new treatment. (2005) (7)
American Stroke Association Stroke Council Update Sea Change for Stroke and the American Stroke Association (2015) (7)
Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial (2015) (6)
Factor VIIa for ICH: Behind the Scenes of an Academic–Industry Collaborative Trial (2007) (6)
Advances in Acute Stroke Treatment 2020. (2021) (6)
Abstract 74: Early Arterial Recanalization After Intra-venous Tissue-Plasminogen-Activator Treatment in the Interventional Management of Stroke-3 Study (2014) (6)
Devices and clinical trials: overview and equipoise. (2013) (6)
American Stroke Association Stroke Council update. (2014) (6)
The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics (2006) (6)
The effects of study participation in the Familial Intracranial Aneurysm Study on cigarette smoking. (2008) (6)
Severe carotid stenosis and delay of reperfusion in endovascular stroke treatment: an Interventional Management of Stroke-III study. (2018) (6)
Assessing stroke incidence and mortality Across the United States (2011) (6)
Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data (2016) (6)
Lessons Learned from Phase II and Phase III Trials Investigating Therapeutic Agents for Cerebral Ischemia Associated with Aneurysmal Subarachnoid Hemorrhage (2021) (5)
Administration of S-methyl-l-thiocitrulline protects against brain injuries after intracerebral hemorrhage (2014) (5)
Erratum: Acute stroke care in the US: Results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry (Stroke (June 2005) 36, 6 (1232-1240)) (2005) (5)
Letter by Hill et al regarding article, "A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke". (2011) (5)
Toward a modern delivery of stroke care in emerging economies. (2013) (5)
Advantages of a combined approach to recanalization therapy. (2008) (5)
Acute Stroke Imaging Research Roadmap IV: Imaging Selection and Outcomes in Acute Stroke Clinical Trials and Practice (2021) (5)
The Utility of Domain-Specific End Points in Acute Stroke Trials (2021) (5)
Gross underfunding of stroke research (2004) (5)
Rapid Nuclear Factor κB Activation and Cytokine and Heme Oxygenase-1 Gene Expression in Edematous White Matter After Porcine Intracerebral Hemorrhage (2001) (5)
178 – Thrombolysis for Acute Ischemic Stroke (1997) (5)
Recent advances in stroke management. (2000) (4)
Pearls & Oy-sters: Isolated cerebral zygomycosis in an intravenous drug user (2011) (4)
Common Data Elements for Unruptured Intracranial Aneurysm and Subarachnoid Hemorrhage Clinical Research: Recommendations from the Working Group on Long-Term Therapies (2019) (4)
AHA/ASA Expert Consensus Document (2013) (4)
Haemostatic treatment for intracerebral haemorrhage (2018) (4)
Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial (2018) (4)
Incontinence and gait disturbance after intraventricular extension of intracerebral hemorrhage (2016) (4)
Diffusion-Weighted Imaging, MR Angiography, and Baseline Data in a Systematic Multicenter Analysis of 3,301 MRI Scans of Ischemic Stroke Patients—Neuroradiological Review Within the MRI-GENIE Study (2020) (4)
Age Accounts for Racial Differences in Ischemic Stroke Volume in a Population-Based Study (2008) (4)
Three-dimensional model-guided segmentation and analysis of medical images (1992) (4)
Associations of Early Systolic Blood Pressure Control and Outcome After Thrombolysis-Eligible Acute Ischemic Stroke: Results From the ENCHANTED Study (2021) (4)
Abstract 7: Differential Effect of Baseline Cta Collateral Status on Clinical Outcomes in Patients Enrolled in the Ims-3 Trial (2014) (4)
Efficiency of enrollment in a successful phase II acute stroke clinical trial. (2012) (3)
What is the median volume of intracerebral hemorrhage and is it changing? (2021) (3)
Prehospital and Emergency Department Care of the Patient with Acute Stroke (2004) (3)
Interferon beta treatment of multiple sclerosis (1994) (3)
Abstract 79: Chronic and Acute Hypertension in Ischemic Stroke Are Distinct Markers of Impaired Collateral Circulation. (2018) (3)
Stroke Recovery & Rehabilitation Research: Issues, Opportunities, and the NIH StrokeNet (2017) (3)
Stroke and Migraine (1997) (3)
Antihypertensives are administered selectively in emergency department patients with subarachnoid hemorrhage. (2013) (3)
Erratum: Unruptured intracranial aneurysms in the Familial Intracranial Aneurysm and International Study of Unruptured Intracranial Aneurysms cohorts: Differences in multiplicity and location. Clinical article (Journal of Neurosurgery (2012) DOI: 10.3171/2012.4.JNS111822) (2012) (3)
Definition of Stroke for the 21 st Century : A Statement for Healthcare (2013) (3)
Abstract WP5: Collaterals in the Interventional Management of Stroke (IMS) III Trial (2013) (3)
Intracranial Aneurysm Classifier Using Phenotypic Factors: An International Pooled Analysis (2022) (3)
Original and Modified Graeb Score Correlation With Intraventricular Hemorrhage and Clinical Outcome Prediction in Hyperacute Intracranial Hemorrhage (2020) (3)
A Phase III, prospective, double-blind, randomized, placebo-controlled trial of thrombolysis in imaging-eligible, late-window patients to assess the efficacy and safety of tenecteplase (TIMELESS): Rationale and design (2022) (3)
Logistics in Acute Stroke Management (2012) (3)
The practice of carotid revascularization in a large metropolitan population. (2013) (3)
Factors and Outcomes Associated With Temporal Bone Resection for Primary Parotid Malignancy (2021) (3)
Abstract 187: Impact of General Anesthesia on Safety and Outcomes in the Endovascular Arm of IMS III (2014) (3)
Intracerebral hemorrhage. (2002) (3)
Exome-chip association analysis of intracranial aneurysms (2019) (3)
Overview of stroke care in the United States and beyond. (2006) (2)
Interferon beta treatment of multiple sclerosis. Authors' reply (1994) (2)
Abstract TP2: Heparin Use Across Major Endovascular Trials (2016) (2)
A Person with Factitious Disorder Presenting with Acute Stroke-Like Symptoms and Receiving Thrombolytic Therapy Twice (2012) (2)
Improving Early Referral and Emergency Care in Acute Stroke (1998) (2)
Timing is everything in intracerebral hemorrhage. (2008) (2)
Abstract 162: The Challenges of Decision-making Regarding Futility in a Randomized Trial: The IMS III Experience (2013) (2)
Measuring treatment effect in acute stroke trials. (2006) (2)
Abstract T P367: Stable Childhood Stroke Rates Over 17 years: Report From a Population-Based Study (2015) (2)
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults 2007 Update A Guideline the Interdisciplinary Group (2007) (2)
Modeling acute lesion volume and topography for genetic analysis ( MRI-GENIE study ) (2)
801 Effects of Recombinant Activated Factor VII on Perilesional Edema in Patients with Acute Intracerebral Hemorrhage. (2005) (2)
Stroke: Warning signs and potential risk factors (1999) (2)
Mortality and Causes of Death in the Familial Intracranial Aneurysm Study (2013) (2)
Matrix metalloproteinase-2 deletions protect against hemorrhagic transformation after 1 hour of cerebral ischemia and 23 hours of reperfusion (2013) (2)
Bayesian selective response‐adaptive design using the historical control (2018) (2)
Collaterals in the Interventional Management of Stroke (IMS) III Trial (P05.226) (2013) (2)
Professionals From the American Heart Association/American Stroke Association An Updated Definition of Stroke for the 21st Century : A Statement for Healthcare (2013) (2)
Abstract W MP73: EMS Triage of Stroke Patients by Stroke Severity: Estimated Impact and Call to Action (2015) (2)
Intravenous thrombolysis for acute stroke. (2004) (2)
Practice Patterns for Acute Ischemic Stroke Workup: A Longitudinal Population‐Based Study (2017) (2)
Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry (2019) (2)
TITLE : Diabetes : a Risk Factor for Ischemic Stroke in a Large Bi-Racial Population COVER TITLE : Diabetes : a Risk Factor for Ischemic Stroke (2)
American Stroke Association Stroke Council Update. (2017) (2)
Endovascular Therapy Demonstrates Benefit over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale (2016) (2)
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Results of Large, Randomized Clinical Trials (2001) (2)
Comparison of Recanalization during EKOS MicroLysus Catheter-Assisted versus Standard Microcatheter Thrombolysis: ISC 132 (2006) (2)
Diabetes Mellitus A Risk Factor for Ischemic Stroke in a Large Bi-Racial Population (2013) (2)
Abstract WMP56: Genetics of Acute Ischemic Lesion Volume: the MRI-Genetics Interface Exploration (MRI-GENIE) Study (2018) (1)
Abstract 141: Atrial Cardiopathy And Left Ventricular Dysfunction In Patients With ESUS: Findings From The Arcadia Trial (2022) (1)
Abstract 82: Endovascular Therapy Eligibility in the Advent of DAWN and DEFUSE-3 Results (2018) (1)
Trends in Substance Abuse Preceding Stroke in Young Adults: An Update (S55.004) (2014) (1)
Thrombolysis in Mild Stroke (2021) (1)
Childhood stroke: comparison of strokes identified in administrative databases with those identified in a population-based study (P1.072) (2015) (1)
Abstract W P274: Characterizing The “Universe” Of Transitional Care Programs For Stroke Survivors In The United States (2015) (1)
Abstract WP177: Trends In The Clinical Phenotype Of Infective Endocarditis Related Stroke From 2005-2015: A Population-Based Study Of The Greater Cincinnati/ Northern Kentucky Region (2022) (1)
Abstract 185: Residual Stroke Morbidity and Post-acute Care Cost: the IMS III Economic Data Cohort (2016) (1)
Abstract 145: Is the Rate of Ischemic Stroke Incidence Changing Differentially Over Time for Women and Men? (2013) (1)
Abstract WP78: The Cost of Alteplase Has More Than Doubled Over the Past Decade (2016) (1)
Abstracts of the Neurocritical Care Society 9th Annual Meeting. September 21-24, 2011. Montreal, Canada. (2011) (1)
Abstract 143: Evaluation of Interval Times from Onset to Recanalization in Patients Undergoing Endovascular Therapy in the IMS III Trial (2014) (1)
The Adverse Effect of Spasticity on 3-Month Poststroke Outcome Using a Population-Based Model (2014) (1)
Abstract T P231: Does Intraventricular Hemorrhage Lead to a Normal Pressure Hydrocephalus-Like Syndrome? (2014) (1)
Acute Stroke Imaging Research Roadmap II Special Reports (2013) (1)
PRIORITIZATION OF RESULTS FROM WHOLE EXOME SEQUENCING IN FAMILIAL INTRACRANIAL ANEURYSM (2012) (1)
Abstract WP205: Pipeline for Automated White Matter Hyperintensity Segmentation in Patients With Acute Ischemic Stroke: The MRI-GENIE Study (2017) (1)
Acute and Interventional Treatments. (2023) (1)
Abstract 184: Drivers of Costs Associated With Reperfusion Therapy in Acute Stroke: The IMS III Trial (2014) (1)
Abstract WMP26: Missense Mutation in COL22A1 is Associated With Intracranial Aneurysms (2016) (1)
Abstract 3192: A Descriptive Study of Interventional Management of Stroke III Trial Investigator Recruitment Enhancement Strategies (2012) (1)
Abstract TP164: Incidence and Temporal Trends in In-hospital Stroke: a Preliminary Analysis From the Greater Cincinnati/Northern Kentucky Stroke Study (2016) (1)
Efficacy of intraarterial thrombolysis of basilar artery stroke. (1999) (1)
Abstract T MP63: Temporal Trends in Stroke Incidence Over the Past Twenty Years: Stroke Incidence Has Stabilized, Racial Disparity is not Improving (2014) (1)
Heritability of territory of ruptured and unruptured intracranial aneurysms in families (2020) (1)
The Use of Linkage Data To Prioritize Results from Whole Exome Sequencing in Familial Intracranial Aneurysm (S53.001) (2012) (1)
Author Correction: Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors (2020) (1)
Recruitment in Acute Stroke Trials: Challenges and Potential Solutions. (2022) (1)
Intracerebral hemorrhage. (1993) (1)
Incidence Rates of Ischemic Stroke in Diabetics: Preliminary Race-Specific Results from the Greater Cincinnati/Northern Kentucky Stroke Study (2001) (1)
Abstract 80: Trends in Anticoagulant-Associated Intracerebral Hemorrhage and Cardioembolic Ischemic Stroke (2015) (1)
Disentangling the Association Between Neurologic Deficits, Patient-Reported Impairments, and Quality of Life After Ischemic Stroke (2023) (1)
Genome-wide SNP Linkage Screen for Intracranial Aneurysm Susceptibility Genes (2007) (1)
Effects of intensive blood pressure lowering on cerebral ischaemia in thrombolysed patients: insights from the ENCHANTED trial (2023) (1)
Abstract 119: Risk of Intracerebral Hemorrhage with Combined Antiplatelet and Anticoagulant Use (2013) (1)
Abstract TMP10: A Retrospective Comparison of Medical Eligibility for Acute Ischemic Stroke Clinical Trials Compared with Hospital Enrollment Rates: Greater Cincinnati/Northern Kentucky Population (2016) (1)
The Role of the Emergency Department in Optimizing the Effect of rFVIIA in the Acute Treatment of Spontaneous Intracerebral Hemorrhage (2006) (1)
Abstract 3559: Differential Effect of High Cholesterol by Intracerebral Hemorrhage Location (2012) (1)
Introduction to Reperfusion (2009) (1)
Abstract WP7: Critical Importance Of Enrollment Hours For Successful Recruitment In Acute Stroke Trials (2022) (1)
Abstract 117: Apolipoprotein E and use of Statins in Intracerebral Hemorrhage (2013) (1)
An Analysis of Factors Associated with Early Intracerebral Hemorrhage (ICH) Growth (2001) (1)
Abstract 98: Stroke Recurrence Rates are Not Changing over Time (2014) (1)
Letter by Hasan et al Regarding Article, "Aspirin and Risk of Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis". (2017) (1)
Effect of Cilostazol in Animal Models of Cerebral Ischemia and Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis. (2022) (1)
Abstract TMP58: Preliminary Population-Based Temporal Trends in Stroke Incidence: Racial Disparity and Stroke Incidence From 1993-2015 (2019) (1)
Response to Letter by Silva et al (2008) (0)
Abstract 3726: Rate of Inappropriate Statin Use after Intracerebral Hemorrhage (2012) (0)
Abstract TP28: Combining Clinical with Radiographic Criteria to Select Patients for Endovascular Therapy in Acute Stroke (2013) (0)
Early Stent Patency After Endovascular Therapy for Tandem or Isolated Carotid Steno-Occlusive Disease. (2023) (0)
Contents Vol. 34, 2012 (2012) (0)
The Potential Role of rFVIIa in the Acute Treatment of Spontaneous Intracerebral Hemorrhage in the Emergency Department (2005) (0)
Abstract TP170: Age and Race Disparities of Cardioembolic and Cryptogenic Strokes Over Time (2017) (0)
391: Emergency Department Stroke Care is Similar by Race and Type of Hospital Within a Regional Population (2008) (0)
Abstract WP274: No Improvement in Emergency Medical Services Use by Stroke Patients From 1999-2015: A Population-Based Study (2020) (0)
A hierarchical statistical modeling approach to indentify patient- and hospital-level determinants of the quality of acute stroke care (2008) (0)
Genomewide Screen for Intracranial Aneurysm Susceptibility Genes (2006) (0)
Abstract W P4: Time to Angiographic Reperfusion: A Decision Analysis (2014) (0)
The Role of Discharge Disposition in the Interventional Management of Stroke (IMSIII) Trial (P1.062) (2015) (0)
Making the Right Call: Human Biases and Still Learning Machines. (2021) (0)
Abstract TP429: Arcadia versus Other Esus Trials: Comparison of Patient Characteristics (2020) (0)
Abstract 72: Temporal Trends in Stroke Incidence Over Time by Sex and Age in the Greater Cincinnati Northern Kentucky Stroke Study (2020) (0)
Abstract WP176: Prior TIAs Among Patients With Ischemic Stroke In The Greater Cincinnati Northern Kentucky Stroke Study (GCNKSS) (2023) (0)
Abstract 185: Declining Subarachnoid Hemorrhage Case-Fatality Rates in a Population (2012) (0)
Abstract 159: Posterior Communicating Artery Flow Diversion in Middle Cerebral Artery Stroke: Angiographic Evidence from IMS III (2016) (0)
Frequency of Abnormal Lab Values in Patients Presenting to the Emergency Department with Acute Ischemic Stroke (2007) (0)
Optimal Randomization Designs for Large Multicenter Clinical Trials: From the National Institutes of Health Stroke Trials Network Funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke Experience. (2023) (0)
Abstract P716: Factors Associated With Functional Dependence at Hospital Discharge in Patients With Low NIHSS Strokes Who Do Not Receive Intravenous Alteplase (2021) (0)
Acute stroke imaging research roadmap II | NOVA. The University of Newcastle's Digital Repository (2013) (0)
Abstract WP239: Potential Impact of C-STAT for Prehospital Stroke Triage up to 24 Hours on a Regional Comprehensive Stroke Center (2018) (0)
Comorbidity Profile of Spasticity within a Cohort of Post-Stroke Survivors (P07.229) (2013) (0)
Stroke Severity at Presentation to the Emergency Department Varies by Time of Day: Results of a Population-based Study (2007) (0)
Co-Occurrence of Sj/ITPR1 and NMDA Antibodies: A Case Report (2022) (0)
Why Are Women Less Represented in Intracerebral Hemorrhage Trials? (2021) (0)
Abstract 359 Role of the emergency department in optimizing the effect of rFVIIa in the acute treatment of spontaneous intracerebral hemorrhage (2006) (0)
Abstract 71: Temporal Trends In 30-day And 5-year Stroke Case Fatality Rates (2023) (0)
Abstract TMP58: Determinants of White Matter Hyperintensity in Acute Ischemic Stroke Patients: The MRI-GENIE Study (2017) (0)
Genomic Analysis of Leukocyte mRNA Suggests Immune Predisposition to Hemorrhagic Transformation in Ischemic Stroke (S42.006) (2013) (0)
Effect of IV rtPA in Mild Strokes in the Third International Stroke Trial (IST3) (S35.003) (2014) (0)
Abstract P787: Sexually Dimorphic Gene Expression Molecular Correlates of Improvement in Human Ischemic Stroke (2021) (0)
Abstract 182: The CLEAR Trials: A Pooled Analysis of rt-PA plus Eptifibatide for Treatment of Acute Ischemic Stroke (2016) (0)
I N 2007, National Estimates from the Nationwide Inpatient Sample Reported That 4.9% of All Strokes in the United States Were in Adults Aged between 18 and 44 Years (0)
Abstract T P135: Geographic Microtargeting: Identifying High Risk Stroke Populations (2014) (0)
Abstract 67: RNA Expression Differentiates Large Artery And Cardioembolic Stroke: A Pilot Analysis From The BASE Trial (2018) (0)
Abstract 6: Results From the DEFUSE 3 Trial: Good Leptomeningeal Collaterals Are Associated With Reduced Core Infarct Size but Not Improved Neurologic Outcome (2019) (0)
Changing Trends in Demographics, Risk Factors, and Clinical Features of Patients With Infective Endocarditis–Related Stroke, 2005–2015 (2023) (0)
Abstract TP215: Leukocyte RNA Expression Is Altered Prior To Hemorrhagic Transformation In Ischemic Stroke (2013) (0)
Abstract TMP25: Effects of Age and Ethnicity on the Benefits and Risks of Low- versus Standard-dose Alteplase in Acute Ischemic Stroke Patients: The Enchanted Trial (2017) (0)
r ecanalization and clinical Outcome of Occlusion s ites at Baseline cT angiography in the interventional Management of (2014) (0)
Abstract T MP72: Temporal Trends in Public Awareness of Stroke Warning Signs and Risk Factors (2014) (0)
Blinding of outcome assessors and its association with outcome in a randomized open-label stroke trial. (2022) (0)
◼ multidetector computed tomography ◼ stroke Multicenter Accuracy and Interobserver Agreement of Spot Sign Identification in Acute Intracerebral Hemorrhage (0)
Advances in Stroke: Treatments-Acute. (2022) (0)
ESPRIT trial (2006) (0)
Abstract TP43: Evaluating the Generalizability of the Common Odds Ratio: A Demonstration using Two Trials of Endovascular Therapy (2019) (0)
Abstract P224: Management of TIA Over Time in the Greater Cincinnati Northern Kentucky Stroke Study (2021) (0)
Abstract TP11: Acute Stroke Randomized Clinical Trials: What Factors Help Trials Achieve Their Intended Sample Size? (2023) (0)
Reply from the authors [4] (2007) (0)
Contents Vol. 5, 2016 (2016) (0)
19th Workshop of the International Stroke Genetics Consortium, April 28–29, 2016, Boston, Massachusetts, USA (2017) (0)
Abstract TP392: Temporal Trends in Practice Patterns for Acute Ischemic Stroke Workup: A Population-Based Study (2013) (0)
Abstract T P365: Childhood Stroke: ICD-9 Code Positive Predictive Values for Identifying Hemorrhagic and Ischemic Events (2015) (0)
Faculty Opinions recommendation of Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. (2008) (0)
Abstract WMP3: Grade 2 or Partial Collaterals in IMS III: Half Full or Half Empty? (2016) (0)
Abstract TP72: The PRISMS Trial: Baseline Characteristics of the First 100 Subjects (2016) (0)
Future Perspectives in Stroke Management (2015) (0)
Abstract 201: Effect of Endovascular Reperfusion in Relation to Site of Arterial Occlusion: A Pooled Analysis of Individual Patient Data (2015) (0)
TCD Velocities and Arterial Pressures in AVM Feeder Vessels (0)
Substance Use and Performance of Toxicology Screens in the Greater Cincinnati Northern Kentucky Stroke Study (2022) (0)
Open letter to health ministers at Framework Convention on Tobacco Control (2003) (0)
Organizational update: American Heart Association Stroke Council. (2014) (0)
Broderick and Hacke Treatment of Acute Ischemic Stroke : Part I 1565 (2002) (0)
Abstract TP423: Predictors of Elevated P Wave Terminal Force and NT-proBNP Differ in the ARCADIA Trial (2020) (0)
Thrombolytic Therapy: Introduction (2004) (0)
Using Epidemiological Data to Inform Clinical Trial Feasibility Assessments: A Case Study (2023) (0)
the Stroke Imaging Research (STIR) and Virtual International Stroke Trials Archive (VISTA)-Imaging Investigators Acute Stroke Imaging Research Roadmap II Special Report (2013) (0)
Early Versus Late Assessment of Stroke Outcome Controversies in Stroke (2016) (0)
Cosponsoring Organizations: JOINT SECTION OF CEREBROVASCULAR SURGERY OF THE AMERICAN ASSOCIATION OF NEUROLOGICAL SURGEONS AND THE CONGRESS OF NEUROLOGICAL SURGEONS CANADIAN STROKE SOCIETY Canadian Heart Foundation AMERICAN NEUROLOGICAL ASSOCIATION THE SOCIETY FOR VASCULAR SURGERY (2005) (0)
Abstract WP192: Ischemic Stroke Mechanisms By Sex And Race Over Time In The Greater Cincinnati Northern Kentucky Stroke Study (2022) (0)
Abstract TMP5: Secondary Analysis of Eptifibatide Plus Full Dose rt-PA in Ischemic Stroke (2016) (0)
A Thrombolytic Therapy with Potential: The PROACT II Study (2000) (0)
Abstract T P199: Severity-adjusted Re-analysis of the Phase 2 Clear-er Stroke Trial (2014) (0)
Top Ten Things To Know Relationship of National Institutes of Health Stroke Scale to 30-Day Mortality in Medicare Beneficiaries With Acute Ischemic Stroke (2012) (0)
Abstract 3698: Ischemic Stroke Etiology in a Population Based Study: Temporal Trends in Ischemic Stroke Subtyping Over Time (2012) (0)
A special thanks to our Ad hoc reviewers (1999) (0)
Abstract TMP102: Timing Of Withdrawal Of Antithrombotics And Impact On Stroke (2022) (0)
Abstract WP190: Clinical Features of Sarcoid Patients With Ischemic Stroke (2016) (0)
Abstract WP251: Long Term Outcome Prediction After Ischemic Stroke Using Gene Expression (2022) (0)
Review of t-PA Use Since FDA Approval (2009) (0)
Abstract T MP21: Effect of IV rtPA in Mild Strokes in the Third International Stroke Trial (IST3): A Post Hoc Analysis (2014) (0)
Emergency Medical Services (EMS)Response and Transport Time for Stroke in an Urban African-American Population: Effect of Socio-demographics of the Patient’s ZIP Code (2000) (0)
Author Correction: Genome-wide association study of intracranial aneurysms identifies 17 risk loci and genetic overlap with clinical risk factors (2020) (0)
The Physiologic Time Window in Acute Stroke (2009) (0)
Abstract TP213: Arcadia CSI (Cognition And Silent Infarcts): Update (2022) (0)
Abstract 2532: Improving Motor Recovery after Stroke: Opportunities for FLAME Study Results (2012) (0)
Devices and Clinical Trials Overview and Equipoise Interventional Treatment of Acute Ischemic Stroke (2013) (0)
Smoking Cessation After Stroke: Education and its Effect on Behavior (2001) (0)
Abstract WMP77: Anticoagulation-Associated Intracerebral Hemorrhage Incidence Rates: A Longitudinal Population-Based Assessment (2022) (0)
Abstract TMP38: Remote Research Practices Enhance Acute Stroke Clinical Trial Enrollment (2023) (0)
Chromosome 7 Linked to Intracranial Aneurysm in Novel Genetic Finding (2014) (0)
Abstract TP60: Comparison of Predicted vs. Actual Enrollment Into the NIH StrokeNet DEFUSE 3 Trial: Effectiveness of a Population-Based Epidemiology Feasibility Assessment in Improving Enrollment Into Clinical Trials (2019) (0)
Abstract TMP108: Ongoing Use and Withdrawal of Antithrombotic Medication for Medical Procedures in the Greater Cincinnati population (2013) (0)
Abstract WMP107: Temporal Trends In Public Awareness Of Stroke: 1996-2021 (2023) (0)
Biomarkers of Acute Stroke Etiology (BASE) Study Methodology (2017) (0)
Contributions Initial and Recurrent Bleeding Are the Major Causes of Death Following Subarachnoid Hemorrhage (2005) (0)
Abstract WP25: A Novel Adaptive Trial Design Increases the Power of Endovascular Stroke Studies (2016) (0)
FIA II Seeks Genetic Underpinnings of Familial Intracranial Aneurysm (2012) (0)
Endovascular Intervention Beneficial in Pooled Analysis of MR CLEAN and IMS III (2015) (0)
Abstract T P12: Intraarterial (IA) Iodinated Radiographic Contrast Media (IRCM) Effect in the Interventional Management of Stroke (IMS) III Trial (2015) (0)
Princeton Conference XXVIII—Cincinnati, Ohio (2013) (0)
Abstract P602: Stroke Risk Factors Among the Young Over Time in the GCNKSS (2021) (0)
Abstract WMP5: How Do Clinical Trial Exclusion Criteria Impact The Inclusivity Of Clinical Trials? (2023) (0)
Abstract 129: Endovascular Therapy Demonstrates Benefit over IV-tPA based on 90-day NIHSS: A Longitudinal, Secondary Analysis of the IMS III Trial (2015) (0)
IMS III: Results and Perspective (2013) (0)
Primary Intracerebral Hemorrhage and Subarachnoid Hemorrhage in Black Patients: Risk Factors, Diagnosis, and Prognosis. (1999) (0)
Abstract P121: Update on Regional Stroke Activation Trends During Covid-19 Mitigation (2021) (0)
Response to Letter by Morikawa (2008) (0)
Abstract W P12: Baseline Predictors of the Malignant Collateral Profile in IMS III (2015) (0)
Abstract WP9: Impact of Sex Differences on the Treatment Effect of Mechanical Thrombectomy: A Subgroup Analysis of the RESILIENT Trial (2020) (0)
Abstract P264: Trends in Diagnostic Testing and Mechanism of Stroke Determination (2021) (0)
Combinations of Intravenous and Intra-Arterial Thrombolysis (2005) (0)
Abstract 3122: Delays in Warfarin Reversal following Intracerebral Hemorrhage: A Population-Based Study (2012) (0)
Abstract 139: Trends in Ischemic Stroke Subtype Over a 17-Year Period (2017) (0)
Abstract WP176: Temporal Trends in Public Awareness of Stroke: Knowledge is Key (2018) (0)
Abstract WMP54: Updated Population Trends in Substance Abuse Preceding Stroke in Young Adults: 1993/1994 to 2015 (2019) (0)
Abstract TP4: Age is an Important Effect Modifier of Mechanical Thrombectomy: A Subgroup Analysis of the Resilient Trial (2020) (0)
MANAGEMENT OF HYPERLIPIDEMIA AND STROKE (2000) (0)
Combination of Intravenous t-PA and Endovascular Therapy (2015) (0)
Teaching NeuroImages: Crying thalamus (2017) (0)
Abstract 26: Predictors of Atrial Cardiopathy Among Patients in the Arcadia Trial: An Analysis of the First 924 Patients (2020) (0)
Treatment of Cerebral Venous Thrombosis: Heparin or Thrombolysis? (1999) (0)
Abstract 138: Plasma Soluble ST2 Concentration Predicts Functional Outcome and Hemorrhagic Transformation After Acute Ischemic Stroke (2017) (0)
Remote Research Practices Enhance Acute Stroke Clinical Trial Enrollment (S10.010) (2023) (0)
Abstract WP73: Automatic Classification of Clinical MRI Stroke Datasets With a Recurrent Convolutional Neural Network (2020) (0)
Premorbid stroke risk factors and medication use in patients with incident stroke: A comparison of United Kingdom and united states population-based studies (2006) (0)
Abstract TMP77: To Treat or Not to Treat? A Survey Exploring Factors Influencing rt-PA Treatment Decisions for Minor Stroke (2018) (0)
Timing, testing, and standardization of endovascular therapy (2012) (0)
Abstract W P19: Propensity Scores Facilitate Unbiased Comparison of Endovascular Devices in IMS III (2014) (0)
Sedation Practice Patterns in Acute Stroke Endovascular Therapy: The IMS III Trial Experience (2011) (0)
Abstract T MP6: The Effect of Proximal Arterial Stenosis on Outcomes Following Interventional Therapy for Acute Ischemic Stroke in the IMS-III Trial (2015) (0)
Abstract WP204: Genetic Variant in VCAM1 Mediates Acute Infarct Size in Ischemic Stroke Patients (2017) (0)
Abstract 198: Relationship Between 24 Hour Infarct Volume And Clinical Outcomes In IMS 3 (2015) (0)
Familial Cerebral Cavernous Malformation Mimicking Cerebral Amyloid Angiopathy. (2021) (0)
Abstract T MP8: Faster Angiographic Reperfusion is Associated with Improved Outcomes Across the Full Rankin Distribution: An Ordinal Analysis of the IMS III Trial (2015) (0)
Abstract 136: Genetics of White Matter Hyperintensity Burden in Patients With Ischemic Stroke: The MRI-GENIE Study (2017) (0)
Racial Variations in Location of Intracerebral Hemorrhage (2018) (0)
Abstract W P7: Difficulty of Catheter Access to Occluded Target Vessel Predicts Worse Recanalization and Poor Outcomes (2014) (0)
Abstract 7: Quality Of Life Trajectories In The Year After Large Vessel Occlusion Stroke And Their Association With 90-day Functional Outcome (2022) (0)
Abstract WP47: Telemedicine And Remote Research Practice Use In Clinical Trials Among StrokeNet Sites (2023) (0)
Organizational Update: American Stroke Association Stroke Council Update. (2016) (0)
160 Carotid Stenosis Significantly Delays Reperfusion During Endovascular Treatment of Stroke in the IMS-III Trial (2015) (0)
Abstract 2578: Methods of Recruitment into Familial Intracranial Aneurysm Study (2012) (0)
Abstract 202: 2B or Not to Be? Defining Successful Reperfusion In IMS III (2015) (0)
Endothelial dysfunction and atherothrombotic occlusive disease. Discussion (1997) (0)
Abstract WP77: Final Infarct Volume May Predict Functional Outcome After Mild, Nondisabling Ischemic Stroke: Results From the PRISMS Trial (2020) (0)
Reply: (2017) (0)

This paper list is powered by the following services:

Joseph P. Broderick

Joseph P. Broderick's Academic­Influence.com Rankings

Joseph P. Broderick's Degrees

Why Is Joseph P. Broderick Influential?

Joseph P. Broderick's Published Works

Published Works

What Schools Are Affiliated With Joseph P. Broderick?

Joseph P. Broderick's AcademicInfluence.com Rankings